Health
Biotech Industry Updates
Several biotech companies have made significant moves, including GSK's $10.6 billion acquisition of Nuvalent and AstraZeneca's GLP-1 pill trial success. These developments reflect ongoing advancements in pharmaceutical research.
Coverage timeline — 3 articles
STAT News
GSK agreed to buy Nuvalent, a cancer drug developer, in a deal worth $10.6 billion, as the company continues its expansion in oncology
2026-06-09 13:39 UTC
STAT News
The NIH has appointed researcher John Powers III to lead its infectious disease institute on an acting basis, after weeks of being in leadership limbo.
2026-06-09 14:50 UTC
STAT News
AstraZeneca's GLP-1 pill, GSK's $10.6B cancer startup acquisition, and more biotech news from The Readout
2026-06-09 15:11 UTC